Biotech · Private company
Mundipharma Research Limited
Track this companyFree. Adds Mundipharma Research Limited to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- FluconazolePhase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- PosaconazolePhase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- Rezafungin for InjectionPhase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- Trimethoprim-sulfamethoxazole (TMP/SMX)Phase 3 · CandidemiaClinicalTrials.gov · fetched Nov 12, 2026
- Tinostamustine 100mg/m2 over 30minPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tinostamustine 100mg/m2 over 60minPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tinostamustine 60mg/m2 over 30minPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tinostamustine 60mg/m2 over 60minPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tinostamustine 80mg/m2 over 30minPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Tinostamustine 80mg/m2 over 60minPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TinostamustinePhase 1 · Hematological MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationPHASE3 · COMPLETED · started May 11, 2020ClinicalTrials.gov NCT04368559 · fetched Nov 12, 2026
- Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.PHASE1_PHASE2 · COMPLETED · started Nov 8, 2017ClinicalTrials.gov NCT03345485 · fetched Nov 12, 2026
- Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic MalignanciesPHASE1 · COMPLETED · started Apr 14, 2016ClinicalTrials.gov NCT02576496 · fetched Nov 12, 2026